Statistics
Publications
2
Citations
194
H-Index
2
Active since
2021
Affiliations
Alibaba Group (China)(Current)
Silong Xiang is an author at Alibaba Group (China) specializing in immunotherapy, checkpoint inhibitor therapy, and cancer immunotherapy.
Publications per year
2021–2022
2
2
Toshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto et al. · Investigational New Drugs · 2022 · 48 citations
Life Sciences, Immunology, Oncology +14
1–2 of 2